IDiyas

For the Inventor, By the Inventor

Paddock Wood, United Kingdom

Iain Mair McDonald

USPTO Granted Patents = 13

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 103(Granted Patents)


Location History:

  • Paddock Wood, GB (1995 - 2000)
  • Kent, GB (1998 - 2000)
  • London, GB (2002 - 2006)

Company Filing History:

goldMedal13 out of 20 
 
James Black Foundation Limited
 patents

Years Active: 1995-2006

Loading Chart...
13 patents (USPTO):Explore Patents
1. 7105558 - Gastrin and cholecystokinin receptor lignads (iv) (2006-09-12),
2. 6956053 - Pyrazole derivatives and their use as gastrin and cholecystokin receptor ligands (2005-10-18),
3. 6479531 - Gastrin and cholecystokinin receptor ligands (2002-11-12),
4. 6159994 - Histamine H.sub.3 receptor ligands (2000-12-12),
5. 6080871 - Sulfonamides and sulfamides as H.sub.3 receptor antagonists (2000-06-27),
6. 6057311 - Benzodiazonine derivatives binding to cholecystokinin or gastrin (2000-05-02),
7. 5919829 - Gastrin and cck receptor ligands (1999-07-06),
8. 5847125 - Amino acid derivatives with anticholecystokinin activity (1998-12-08),
9. 5795907 - Gastin and CCK receptor ligands (1998-08-18),
10. 5674905 - Bicyclooctane and bicycloheptane derivatives (1997-10-07),
11. 5514683 - Bicyclo 2,2,2!octane derivatives (1996-05-07),
12. 5486597 - Tetrapeptide derivatives and analogues (1996-01-23),
13. 5399748 - Derivatives of aspartic acid and glutamic acid having (1995-03-21),

Title: Iain Mair McDonald: Innovator in Pharmaceutical Chemistry

Introduction

Iain Mair McDonald is a distinguished inventor based in Paddock Wood, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 13 patents. His work primarily focuses on the development of compounds that act as ligands at gastrin and cholecystokinin receptors.

Latest Patents

Among his latest patents, McDonald has developed compounds of the formula (I) or (II) that serve as ligands at gastrin and/or cholecystokinin receptors. These compounds include various structural features, such as hydrocarbon chains and functional groups, which enhance their pharmaceutical properties. Additionally, he has worked on pyrazole derivatives that also function as ligands at these receptors, further expanding the potential applications of his research.

Career Highlights

Iain Mair McDonald is currently associated with the James Black Foundation Limited, where he continues to innovate in the pharmaceutical sector. His extensive research and development efforts have positioned him as a key figure in the field, contributing to advancements in drug discovery and therapeutic applications.

Collaborations

Some of his notable coworkers include Sarkis Barret Kalindjian and Caroline M Low, with whom he has collaborated on various projects aimed at enhancing the efficacy of pharmaceutical compounds.

Conclusion

Iain Mair McDonald is a prominent inventor whose work in pharmaceutical chemistry has led to numerous patents and significant advancements in drug development. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…